Fintel reports that on January 31, 2025, Stifel upgraded their outlook for C.H. Robinson Worldwide (NasdaqGS:CHRW) from Hold ...

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.

Stifel lowered the firm’s price target on Intel (INTC) to $21 from $25 and keeps a Hold rating on the shares. Q4 results were above management ...

Q4 2024 Earnings Call Transcript January 29, 2025 Stifel Financial Corp. beats earnings expectations. Reported EPS is $2.23, ...

Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Syndax Pharmaceuticals (SNDX – Research Report) today and set a price target ...

Stifel analyst Chris O’Cull raised the firm’s price target on Brinker (EAT) to $200 from $170 and keeps a Buy rating on the shares after what the firm calls “another stellar quarter.” The results are ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of ...

Over the past five years, Stifel has hired 450 advisors, with a cumulative trailing 12-month production of more than $350 million, according to CFO Marischen. That has driven the wealth division’s ...

The natural beauty of West Virginia will be celebrated both musically and visually in the Wheeling Symphony Orchestra’s upcoming performance, “Nature. Beauty.” Set for 2 p.m., Feb. 8, at the Capitol ...

Shares of Stifel Financial were moving higher after it reported fourth-quarter adjusted earnings that beat Wall Street ...

Learn more about whether SEI Investments Company or Stifel Financial Corp. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.